Frontiers SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress

Frontiers The cross-talk of lung and heart complications in COVID-19: Endothelial cells dysfunction, thrombosis, and treatment

Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies

Frontiers SARS-CoV-2 infection as a potential risk factor for the development of cancer

Overcoming Barriers Arteriosclerosis, Thrombosis, and Vascular Biology

Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies

From heart to muscle: pathophysiological mechanisms underlying long-term physical sequelae from SARS-CoV-2 infection

Viruses, Free Full-Text

Frontiers Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis

Biomedicines, Free Full-Text

SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway

An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts

Frontiers Biofunctional roles of estrogen in coronavirus disease 2019: Beyond a steroid hormone

Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches

Journey to a Receptor for Advanced Glycation End Products Connection in Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Frontiers Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection